{"id":288,"date":"2014-03-28T20:38:25","date_gmt":"2014-03-28T20:38:25","guid":{"rendered":"http:\/\/www.imperialcrs.com\/blog\/?p=288"},"modified":"2022-02-22T15:35:11","modified_gmt":"2022-02-22T15:35:11","slug":"risk-share-pitfalls-what-to-look-for","status":"publish","type":"post","link":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/","title":{"rendered":"Risk-Share Pitfalls: What to Look For"},"content":{"rendered":"

Risk share by definition means that each party puts something at risk. Oftentimes in the life-science industry there is one-sided risk and not a lot of sharing. Many companies try and establish standardized processes for risk sharing just to find out that study-specific nuances prevent this from happening.<\/span><\/p>\n

Each study is truly unique in its design and the way it’s operationalized at the site level. Some studies lend themselves to risk share being evaluated on screened patients, while others lend themselves to a referral evaluation. A risk-share program based on randomized patients is very challenging and opens a lot of speculation. It is the research center\u2019s responsibility to enroll a patient into a trial, not the recruitment vendor\u2019s responsibility.<\/p>\n

When developing a risk-share program, consider mutual key performance indicators (KPIs). Ensure all required parties agree to these KPIs being listed in the contract. And be aware of evaluation challenges that may be unforeseen. For example, determining the appropriate tracking mechanism can be difficult.<\/p>\n

In a recent global relapsing-remitting multiple sclerosis study, we decided to use the established IVR system to track during the screening visit how an individual learned about the study. We agreed on the prompt definitions describing the various sources of referral. Training was conducted with the sites on how to mark the appropriate prompts within the system.<\/p>\n

Our risk share was based on screened patients who were attributable to Imperial. At an interim evaluation of the data, we had achieved 30 percent of our target. But upon further analysis, we noticed that some of the recorded prompts were incorrect because, for example, we hadn’t initiated a specific service yet. Therefore, an unplanned detailed analysis had to take place, resulting in us only achieving 21 percent of our goal, which represented a 46 percent decrease from the initial analysis.<\/p>\n

These findings resulted in several observations: (1) despite proper training there still was inaccurate reporting in the IVR system; (2) we needed to reassess how to accurately track the impact of our strategies; and (3) we had to revise the existing risk-share agreement.<\/p>\n

So just keep in mind that desired risk-share agreements may be limited or become null and void if KPIs are not met.<\/p>\n","protected":false},"excerpt":{"rendered":"

Risk share by definition means that each party puts something at risk. Oftentimes in the life-science industry there is one-sided risk and not a lot of sharing. Many companies try and establish standardized processes for risk sharing just to find out that study-specific nuances prevent…<\/p>\n","protected":false},"author":26,"featured_media":69774,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[22,35],"tags":[50,114,34,95,115,116],"class_list":["post-288","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-insights","category-patient-recruitment-and-retention","tag-clinical-trials","tag-key-performance-indicators","tag-patient-recruitment","tag-patient-retention","tag-risk-share","tag-risk-share-agreements"],"acf":[],"yoast_head":"\nRisk-Share Pitfalls: What to Look For - Imperial Clinical Research Services Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Risk-Share Pitfalls: What to Look For - Imperial Clinical Research Services Blog\" \/>\n<meta property=\"og:description\" content=\"Risk share by definition means that each party puts something at risk. Oftentimes in the life-science industry there is one-sided risk and not a lot of sharing. Many companies try and establish standardized processes for risk sharing just to find out that study-specific nuances prevent…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/\" \/>\n<meta property=\"og:site_name\" content=\"Imperial Clinical Research Services Blog\" \/>\n<meta property=\"article:published_time\" content=\"2014-03-28T20:38:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-22T15:35:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2014\/03\/Risk-Share-Pitfalls.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"491\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Melynda Geurts\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Melynda Geurts\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/risk-share-pitfalls-what-to-look-for\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/risk-share-pitfalls-what-to-look-for\\\/\"},\"author\":{\"name\":\"Melynda Geurts\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/6ec8a211b006310db2bcb4c3e3642781\"},\"headline\":\"Risk-Share Pitfalls: What to Look For\",\"datePublished\":\"2014-03-28T20:38:25+00:00\",\"dateModified\":\"2022-02-22T15:35:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/risk-share-pitfalls-what-to-look-for\\\/\"},\"wordCount\":370,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/risk-share-pitfalls-what-to-look-for\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2014\\\/03\\\/Risk-Share-Pitfalls.jpg\",\"keywords\":[\"Clinical Trials\",\"Key Performance Indicators\",\"Patient Recruitment\",\"Patient Retention\",\"Risk Share\",\"Risk Share Agreements\"],\"articleSection\":[\"Business Insights\",\"Patient Recruitment and Retention\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/risk-share-pitfalls-what-to-look-for\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/risk-share-pitfalls-what-to-look-for\\\/\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/risk-share-pitfalls-what-to-look-for\\\/\",\"name\":\"Risk-Share Pitfalls: What to Look For - Imperial Clinical Research Services Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/risk-share-pitfalls-what-to-look-for\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/risk-share-pitfalls-what-to-look-for\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2014\\\/03\\\/Risk-Share-Pitfalls.jpg\",\"datePublished\":\"2014-03-28T20:38:25+00:00\",\"dateModified\":\"2022-02-22T15:35:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/6ec8a211b006310db2bcb4c3e3642781\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/risk-share-pitfalls-what-to-look-for\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/risk-share-pitfalls-what-to-look-for\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/risk-share-pitfalls-what-to-look-for\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2014\\\/03\\\/Risk-Share-Pitfalls.jpg\",\"contentUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2014\\\/03\\\/Risk-Share-Pitfalls.jpg\",\"width\":800,\"height\":491,\"caption\":\"Word writing text Risk Assessment. Business photo showcasing estimation of the levels of risks involved in a situation\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/risk-share-pitfalls-what-to-look-for\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Risk-Share Pitfalls: What to Look For\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/\",\"name\":\"Imperial Clinical Research Services Blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/6ec8a211b006310db2bcb4c3e3642781\",\"name\":\"Melynda Geurts\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fce2a48245fa3072c9d1fc33a746863af615e36126d4eb11bf2645e77c28a990?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fce2a48245fa3072c9d1fc33a746863af615e36126d4eb11bf2645e77c28a990?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fce2a48245fa3072c9d1fc33a746863af615e36126d4eb11bf2645e77c28a990?s=96&d=mm&r=g\",\"caption\":\"Melynda Geurts\"},\"description\":\"Former vice president of operations, Imperial Clinical Research Services. Melynda is a veteran health care industry executive with more than 20 years of experience. An in-demand speaker and presenter, she is invited often to present and train worldwide at industry conferences and client events. She has contributed many articles to the patient recruitment industry\u2019s body of knowledge and is extremely passionate when it comes to educating the public about participation in global clinical research opportunities. Melynda is a past-inductee into the PharmaVoice 100 Most Inspiring People in the Life-Sciences.\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/author\\\/mgeurts\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Risk-Share Pitfalls: What to Look For - Imperial Clinical Research Services Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/","og_locale":"en_US","og_type":"article","og_title":"Risk-Share Pitfalls: What to Look For - Imperial Clinical Research Services Blog","og_description":"Risk share by definition means that each party puts something at risk. Oftentimes in the life-science industry there is one-sided risk and not a lot of sharing. Many companies try and establish standardized processes for risk sharing just to find out that study-specific nuances prevent…","og_url":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/","og_site_name":"Imperial Clinical Research Services Blog","article_published_time":"2014-03-28T20:38:25+00:00","article_modified_time":"2022-02-22T15:35:11+00:00","og_image":[{"width":800,"height":491,"url":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2014\/03\/Risk-Share-Pitfalls.jpg","type":"image\/jpeg"}],"author":"Melynda Geurts","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Melynda Geurts","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/#article","isPartOf":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/"},"author":{"name":"Melynda Geurts","@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/6ec8a211b006310db2bcb4c3e3642781"},"headline":"Risk-Share Pitfalls: What to Look For","datePublished":"2014-03-28T20:38:25+00:00","dateModified":"2022-02-22T15:35:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/"},"wordCount":370,"commentCount":0,"image":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/#primaryimage"},"thumbnailUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2014\/03\/Risk-Share-Pitfalls.jpg","keywords":["Clinical Trials","Key Performance Indicators","Patient Recruitment","Patient Retention","Risk Share","Risk Share Agreements"],"articleSection":["Business Insights","Patient Recruitment and Retention"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/","url":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/","name":"Risk-Share Pitfalls: What to Look For - Imperial Clinical Research Services Blog","isPartOf":{"@id":"https:\/\/www.imperialcrs.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/#primaryimage"},"image":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/#primaryimage"},"thumbnailUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2014\/03\/Risk-Share-Pitfalls.jpg","datePublished":"2014-03-28T20:38:25+00:00","dateModified":"2022-02-22T15:35:11+00:00","author":{"@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/6ec8a211b006310db2bcb4c3e3642781"},"breadcrumb":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/#primaryimage","url":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2014\/03\/Risk-Share-Pitfalls.jpg","contentUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2014\/03\/Risk-Share-Pitfalls.jpg","width":800,"height":491,"caption":"Word writing text Risk Assessment. Business photo showcasing estimation of the levels of risks involved in a situation"},{"@type":"BreadcrumbList","@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/risk-share-pitfalls-what-to-look-for\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.imperialcrs.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Risk-Share Pitfalls: What to Look For"}]},{"@type":"WebSite","@id":"https:\/\/www.imperialcrs.com\/blog\/#website","url":"https:\/\/www.imperialcrs.com\/blog\/","name":"Imperial Clinical Research Services Blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.imperialcrs.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/6ec8a211b006310db2bcb4c3e3642781","name":"Melynda Geurts","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/fce2a48245fa3072c9d1fc33a746863af615e36126d4eb11bf2645e77c28a990?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fce2a48245fa3072c9d1fc33a746863af615e36126d4eb11bf2645e77c28a990?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fce2a48245fa3072c9d1fc33a746863af615e36126d4eb11bf2645e77c28a990?s=96&d=mm&r=g","caption":"Melynda Geurts"},"description":"Former vice president of operations, Imperial Clinical Research Services. Melynda is a veteran health care industry executive with more than 20 years of experience. An in-demand speaker and presenter, she is invited often to present and train worldwide at industry conferences and client events. She has contributed many articles to the patient recruitment industry\u2019s body of knowledge and is extremely passionate when it comes to educating the public about participation in global clinical research opportunities. Melynda is a past-inductee into the PharmaVoice 100 Most Inspiring People in the Life-Sciences.","url":"https:\/\/www.imperialcrs.com\/blog\/author\/mgeurts\/"}]}},"_links":{"self":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/288","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/comments?post=288"}],"version-history":[{"count":1,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/288\/revisions"}],"predecessor-version":[{"id":69775,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/288\/revisions\/69775"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/media\/69774"}],"wp:attachment":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/media?parent=288"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/categories?post=288"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/tags?post=288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}